FDA Inspection 1250040 — Eric B. Creed, D.O.
The FDA completed an inspection of Eric B. Creed, D.O. on Sep 13, 2024 in Chapel Hill, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 13, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Chapel Hill, NC (United States)
Additional Details
Clinical Investigator (CI)